Predictors of Relapse and Functioning in First-Episode Psychosis: A Two-Year Follow-Up Study.
暂无分享,去创建一个
V. Pérez | A. Bulbena | A. Mané | D. Bergé | Romina Cortizo | P. Salgado | C. Garnier | L. Gómez | C. Diez-Aja | R. Cortizo
[1] G. Bond,et al. Essential evidence-based components of first-episode psychosis services. , 2013, Psychiatric services.
[2] K. Hill,et al. The relationship between internalized stigma, negative symptoms and social functioning in schizophrenia: The mediating role of self-efficacy , 2013, Psychiatry Research.
[3] O. Andreassen,et al. Predictors of medication adherence in patients with schizophrenia and bipolar disorder , 2012, Acta psychiatrica Scandinavica.
[4] L. Seidman,et al. The nature and evolution of insight in schizophrenia: A multi-informant longitudinal study of first-episode versus chronic patients , 2008, Schizophrenia Research.
[5] E. Chen,et al. Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study , 2012, Psychological Medicine.
[6] J. Vázquez-Barquero,et al. Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study. , 2012, Journal of psychiatric research.
[7] P. McGorry,et al. Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies , 2012, Schizophrenia Research.
[8] Robin M. Murray,et al. Incidence of Schizophrenia and Other Psychoses in England, 1950–2009: A Systematic Review and Meta-Analyses , 2012, PloS one.
[9] D. Addington,et al. Validity of hospital admission as an outcome measure of services for first-episode psychosis. , 2012, Psychiatric services.
[10] M. Lam,et al. Persistent negative symptoms in first-episode schizophrenia: A prospective three-year follow-up study , 2011, Schizophrenia Research.
[11] Molly A. Erickson,et al. Insight and negative symptoms as predictors of functioning in a work setting in patients with schizophrenia , 2011, Psychiatry Research.
[12] L. Nicole,et al. [Specialised first-episode psychosis services: a systematic review of the literature]. , 2011, L'Encephale.
[13] M. Figueira,et al. [Early intervention in psychosis: first-episode psychosis and critical period]. , 2011, Acta medica portuguesa.
[14] A. Malla,et al. Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years. , 2010, Schizophrenia bulletin.
[15] A. David,et al. Outcome of first-episode schizophrenia in India: longitudinal study of effect of insight and psychopathology , 2010, British Journal of Psychiatry.
[16] S. Hetrick,et al. A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis , 2010, Schizophrenia Research.
[17] M. Bell,et al. Review on Vocational Predictors: A Systematic Review of Predictors of Vocational Outcomes Among Individuals with Schizophrenia: An Update Since 1998 , 2010, The Australian and New Zealand journal of psychiatry.
[18] Jian Kang,et al. Predictors of admission in first-episode psychosis: developing a risk adjustment model for service comparisons. , 2010, Psychiatric services.
[19] S. Cooper,et al. Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. , 2009, The British journal of psychiatry : the journal of mental science.
[20] R. Boellaard,et al. Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum , 2009, Neuropsychopharmacology.
[21] J. Waddington,et al. Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis , 2009, British Journal of Psychiatry.
[22] C. García,et al. [Spanish adaptation of the Scale to Asses Unawareness of Mental Disorder (SUMD)]. , 2008, Actas espanolas de psiquiatria.
[23] P. McGorry,et al. Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis. , 2007, The Journal of clinical psychiatry.
[24] N. Tarrier,et al. Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. , 2007, The Journal of clinical psychiatry.
[25] B. V. Zwieten-Boot,et al. ECNP consensus meeting. Negative, depressive and cognitive symptoms of schizophrenia. Nice, March 2004 , 2007, European Neuropsychopharmacology.
[26] D. Wiersma,et al. Guided Discontinuation Versus Maintenance Treatment in Remitted First-Episode Psychosis: Relapse Rates and Functional Outcome , 2007 .
[27] J. Addington,et al. One-Year Stability of Diagnosis in First-Episode Nonaffective Psychosis: Influence of Sex , 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[28] Peter B. Jones,et al. Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study , 2006, Psychological Medicine.
[29] R. Zipursky,et al. A systematic review of longitudinal outcome studies of first-episode psychosis , 2006, Psychological Medicine.
[30] Brian Kirkpatrick,et al. The NIMH-MATRICS consensus statement on negative symptoms. , 2006, Schizophrenia bulletin.
[31] S. Hutton,et al. Comorbid substance use and age at onset of schizophrenia , 2006, British Journal of Psychiatry.
[32] M. Lambert,et al. Diagnostic stability 18 months after treatment initiation for first-episode psychosis. , 2005, The Journal of clinical psychiatry.
[33] G. Krarup,et al. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness , 2005, BMJ : British Medical Journal.
[34] M. Clarke,et al. Diagnostic stability four years after a first episode of psychosis. , 2005, Psychiatric services.
[35] S. Lewis,et al. Duration of untreated psychosis and its relationship to clinical outcome , 2005, British Journal of Psychiatry.
[36] M. Redoblado-Hodge,et al. Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. , 2005, The Australian and New Zealand journal of psychiatry.
[37] Peter B. Jones,et al. Cannabis use and outcome of recent onset psychosis , 2005, European Psychiatry.
[38] A. Malla,et al. First-episode psychosis: psychopathology, quality of life, and functional outcome. , 2005, Schizophrenia bulletin.
[39] E. Bromet,et al. Long-term diagnostic stability and outcome in recent first-episode cohort studies of schizophrenia. , 2005, Schizophrenia bulletin.
[40] L. San,et al. Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia , 2004, Schizophrenia Research.
[41] S. Sevy,et al. The relationship between insight and symptoms in schizophrenia. , 2004, Comprehensive psychiatry.
[42] J. Lieberman,et al. Predictors of antipsychotic treatment response in patients with first episode schizophrenia, schizoaffective, and schizophreniform disorders , 2003, Schizophrenia Research.
[43] Christian R. Dolder,et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. , 2002, The Journal of clinical psychiatry.
[44] M. Salamero,et al. Versión española de una escala de evaluación de la manía: validez y fiabilidad de la Escala de Young , 2002 .
[45] R. Dal-Ré,et al. Validación de las versiones en español de la Montgomery-Asberg Depression Rating Scale y la Hamilton Anxiety Rating Scale para la evaluación de la depresión y de la ansiedad , 2002 .
[46] Emil Kraepelin,et al. Dementia praecox and paraphrenia , 2002 .
[47] Eduard Vieta,et al. [Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale]. , 2002, Medicina clinica.
[48] E. Laska,et al. Recovery from psychotic illness: A 15- and 25-year international follow-up study , 2001, British Journal of Psychiatry.
[49] R. Buchanan,et al. A separate disease within the syndrome of schizophrenia. , 2001, Archives of general psychiatry.
[50] J. Usall,et al. [Gender differences in schizophrenia. A literature review]. , 2000, Actas espanolas de psiquiatria.
[51] M. Birchwood,et al. Early intervention in psychosis: the critical-period hypothesis , 1998 .
[52] T. McGlashan,et al. The Varied Outcomes of Schizophrenia , 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[53] P. Martín,et al. Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients , 1994 .
[54] P. Dingemans,et al. Cannabis abuse and the course of recent onset schizophrenic disorders , 1993, Schizophrenia Research.
[55] J. Sweeney,et al. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. , 1991, The American journal of psychiatry.
[56] N. Smeeton,et al. The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics. , 1989, Psychological medicine. Monograph supplement.
[57] J. Fleiss,et al. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. , 1976, Archives of general psychiatry.